Browse by category

Publication of the latest data from the National Bariatric Surgical Registry (NBSR) has demonstrated that in-hospital survival from metabolic and bariatric surgery (MBS) is at least as good, if not better, than many common laparoscopic gastrointestinal procedures. Omar Khan Surgical data from metabolic and bariatric surgery (MBS) in England revealed an in-hospital mortality rate of 0.035% with three recorded in-hospital deaths from 8,454 procedures, between March 2023 and Apr

The United States Patent and Trademark Office (USPTO) has issued a new patent to Wayne State University and RediMinds that protects a technology that aims to detect and visualize arterial bleeding during surgeries. US Patent No. 12,635,098 B2 is titled, ‘Systems and Methods for Detecting, Localizing, Assessing and Visualizing Bleeding in a Surgical Field’ and recognises an inventive step forward in addressing intraoperative bleeding, a major complication of minimally invasive

Medtronic has announced significant milestones to unlock expanded indications for the Hugo robotic-assisted surgery (RAS) system in the US. The company has submitted 510(k) clearance for gynaecological surgery, general surgery indication including hernia repair, the LigaSure RAS Maryland instrument and for the ProGrip Advanced mesh for use in robotic-assisted ventral hernia repair. These milestones build momentum for Medtronic's Surgical business and its purposeful launch of

Researchers at New York University Tandon School of Engineering have developed a new stent to treat gastric leaks. Their prototype, called the Lily stent, is the first product of a design framework the researchers named Personalized Endoscopic Transmural Abscess Leak Solution (PETALS), a mathematical approach to optimizing drain shape for complex biological fluids that the team says could be applied beyond gastric leaks to other drainage challenges in the body. Overview of th

Weight loss drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are transforming obesity treatment, but without affordable, healthy food and appropriate support, they could widen health inequalities in the UK, according to researchers at University College London and the University of Cambridge, UK. The researchers argue that while incretin-based therapies, also known as weight loss medications, have transformed obesity treatment, their long-term benefits ma

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Dr Elizabeth McDonald, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing brea